High prevalence of Mycoplasma infections among European chronic fatigue syndrome patients. Examination of four Mycoplasma species in blood of chronic fatigue syndrome patients

FEMS Immunology and Medical Microbiology

Volumn 34, Issue 3, 2002, Pages 209-214

  Nijs, Jo ^a   Nicolson, Garth L ^b   De Becker, Pascale ^a   Coomans, Danny ^c   De Meirleir, Kenny ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b INSTITUTE FOR MOLECULAR MEDICINE   (United States)

^c JAMES COOK UNIVERSITY   (Australia)

Author keywords

Chronic fatigue syndrome; Forensic polymerase chain reaction; Mycoplasma infection; Prevalence

Indexed keywords

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; EUROPE; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA HOMINIS; MYCOPLASMA PENETRANS; MYCOPLASMA PNEUMONIAE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ADOLESCENT; ADULT; DNA, BACTERIAL; EUROPE; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOPLASMA; MYCOPLASMA INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES;

EID: 0037111917     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(02)00398-X     Document Type: Article

References (28)

1. Holmes G.P., Kaplan J.E., Gantz N.M., Komaroff A.L., Schonberger L.B., Straus S.E., Jones J.F., Dubois R.E., Cunningham-Rundles C., Pahwa S., Tosato G., Zegans L.S., Purtilo D.T., Brown N., Schooley R.T., Brus I. Chronic fatigue syndrome, a working case definition. Ann. Intern. Med. 108:1988;387-389.
2. Fukuda, K., Strauss, S.E., Hickie, I., Sharpe, M.C., Dobbins, J.G., Komaroff, A. and the International Chronic Fatigue Syndrome Study Group (1994) The chronic fatigue syndrome, a comprehensive approach to its definition and study. Ann. Intern. Med. 121, 953-959.
3. Nicolson G.L., Nasralla M., Haier J., Erwin R., Nicolson N.L., Ngwenya R. Mycoplasmal infections in chronic illnesses: fibromyalgia and chronic fatigue syndromes, Gulf War illness, HIV-AIDS and rheumatoid arthritis. Med. Sentinel. 4:1999;172-176.
4. Chia J.K.S., Chia L.Y. Chronic Chlamydia pneumoniae infection: a treatable cause of chronic fatigue syndrome. Clin. Infect. Dis. 29:1999;452-453.
5. Vojdani A., Franco A.B. Multiplex PCR for the detection of Mycoplasma fermentans, M. hominis, and M. penetrans in patients with chronic fatigue syndrome, fibromyalgia, rheumatoid arthritis, and Gulf War syndrome. J. Chronic Fatigue Syndr. 3/4:1999;187-197.
6. Nicolson G.L., Nasralla M., Haier J., Nicolson N.L. Diagnosis and treatment of chronic mycoplasmal infections in fibromylagia and chronic fatigue syndromes: relationship to Gulf War illness. Biomed. Ther. 16:1998;266-271.
7. Nasralla M., Haier J., Nicolson G.L. Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia. Eur. J. Clin. Microbiol. Infect. Dis. 18:1999;859-865.
8. Nasralla M.Y., Haier J., Nicolson N.L., Nicolson G.L. Examination of mycoplasmas in blood of 565 chronic illness patients by polymerase chain reaction. Int. J. Med. Biol. Environ. 28:2000;15-23.
9. Nicolson G.L., Nasralla M.Y., Franco A.R., De Meirleir K., Nicolson N.L., Ngwenya R., Haier J. Role of mycoplasmal infections in fatigue illnesses: chronic fatigue and fibromylagia syndromes, Gulf War illness and rheumatoid arthritis. J. Chronic Fatigue Syndr. 6:2000;23-39.
10. Nicolson G.L., Nicolson N.L. Diagnosis and treatment of mycoplamsmal infections in Persian Gulf War illness-CFIDS patients. Int. J. Occup. Med. Immunol. Toxicol. 5:1996;67-78.
11. Baseman J.B., Tully J.G. Mycoplasmas: sophisticated, re-emerging and burdened by their notoriety. Emerg. Infect. Dis. 3:1997;21-32.
12. Baum, S.C. (1995) Mycoplasma diseases. In: Principles and Practice of Infectious Diseases (Mandell, G.L., Bennett, J.E. and Dolin, R., Eds.), pp. 1701-1712. Churchill Livingstone, New York.
13. Johnson S., Sidebottom D., Bruckner F., Collins D. Identification of Mycoplasma fermentans in synovial fluid samples from arthritis patients with inflammatory disease. J. Clin. Microbiol. 38:2000;90-93.
14. Ginsburg K.S., Kundsin R.B., Walter C.W., Schur P.H. Ureplasma urealyticum and Mycoplasma hominis in women with systemic lupus erythematosus. Arthritis Rheum. 35:1992;429-433.
15. Greenlee J.E., Rose J.W. Controversies in neurological infectious diseases. Semin. Neurol. 20:2000;375-386.
16. Layani-Milon M.-P., Gras I., Valette M., Luciani J., Stagnara J., Aymard M., Lina B. Incidence of upper respiratory tract Mycoplamsa pneumoniae infections among outpatients in Rhône-Alpes, France, during five successive winter periods. J. Clin. Microbiol. 37:1999;1721-1726.
17. Al Rashed A. Role of Mycoplamsa pneumoniae in acute respiratory-tract infections in Saudi paediatric patients. Ann. Trop. Med. Parasitol. 92:1998;595-601.
18. Clyde W.A. Clinical overview of typical Mycoplasma pneumoniae infections. Clin. Infect. Dis. 17:1993;S83-S89.
19. Suhadolnik R.J., Reichenbach N.L., Hitzges P., Sobol R.W., Peterson D.L., Henry B., Ablashi D.V., Müller W.E.G., Schröder H.C., Carter W.A., Strayer D.R. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin. Infect. Dis. 18:1994;S96-S104.
20. De Meirleir K., Bisbal C., Campine I., De Becker P., Salehzada T., Demettre E., Lebleu B. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am. J. Med. 108:2000;99-105.
21. Suhadolnik R.J., Peterson D.L., O'Brien K., Cheney P.R., Herst C.V.T., Reichenbach N.L., Kon N., Horvath S.E., Iacono K.T., Adelson M.E., De Meirleir K., De Becker P., Charubala R., Pfleiderer W. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. J. Interferon Cytokine Res. 17:1997;377-385.
22. Bisbal C., Martinand C., Silhol M., Lebleu B., Salehzada T. Cloning and characterization of a RNase L inhibitor. J. Biol. Chem. 270:1995;13308-13317.
23. Martinand C., Montavon C., Salehzada T., Silhol M., Lebleu B., Bisbal C. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L Pathway in Human T Cells. J. Virol. 73:1999;290-296.
24. Simecka J.W., Ross S.E., Cassell G.H., Davis J.K. Interactions of Mycoplasmas with B cells: antibody production and non-specific effects. Clin. Infect. Dis. 17:1993;S176-S182.
25. Baum, S.C. (1995) Mycoplasma pneumoniae and atypical pneumonia. In: Principles and Practice of Infectious Diseases (Mandell, G.L., Bennett, J.E. and Dolin, R., Eds.). Churchill Livingstone, New York, pp. 1704-1713.
26. Piec G., Mirkovitch J., Palacio S., Mühlradt P.F., Felix R. Effect of MALP-2, a lipopeptide from Mycoplasma fermentans, a bone resorption in vitro. Infect. Immun. 67:1999;6281-6285.
27. Swezey R.L., Adams J. Fibromyalgia: a risk factor for osteoporosis. J. Rheumatol. 26:1999;2642-2644.
28. McGrgeor N.R., Niblett S., Bligh P.C., Dunstan R.H., Fulcher G., Hoskin L., Butt H.L., Roberts T.K., King K., Klineberg I. The biochemistry of chronic pain and fatigue. J. Chronic Fatigue Syndr. 7:2000;3-21.